InsidersTradesSigma
Follow the 메쥬 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 메쥬 has recorded 6 insider filings. Market capitalisation: €131bn. The latest transaction was filed on 10 April 2026 (Purchase). Among the most active insiders: 박정환. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
메쥬 es una empresa de salud y farmacéutica que cotiza en el XKRX. Se especializa en el desarrollo y la comercialización de productos farmacéuticos.